Cannabis
ZYUS – SUCCESS PAGE – January 23, 2025
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively without opioids.
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively without opioids.
The company’s AI-powered drug development program has the potential to uncover treatments for multiple diseases and impact millions of lives.
Ingenious, patented micro-hydroelectric energy recovery system produces renewable energy from the water that flows through municipal pipes
Ingenious, patented micro-hydroelectric energy recovery system produces renewable energy from the water that flows through municipal pipes
CH4 Global has created a natural supplement that when added to a livestock feed prevents methane from being produced during digestion.
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
A clinical-stage precision medicine company enhancing patient outcomes through improved decision-making and personalized cancer care.
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively, safely, and compassionately.
Developing drugs aimed at the central nervous system to treat neurological disorders including Alzheimer’s, chronic pain, and obesity
Direct Biologics is a clinical-stage biotech innovator that is harnessing signaling molecules to reduce overactive inflammatory response
Rock Fiber is revolutionizing the $100B structural materials market with its innovative and sustainable, high-performance fiber products.